Univariate analysis | |||
 Pre-transplant factors | Variables (Number) | Mortality (%) | P-value |
  Gender | Male (119) | 19.3 | 0.13 |
Female (65) | 10.8 | Â | |
  Age | ≥60 (80) | 18.8 | 0.42 |
<60 (104) | 14.4 | Â | |
  Diagnosis | Myeloid malignacy (119) | 16.8 | 0.83 |
non Myeloid malignancy (65) | 15.4 | Â | |
  Diseases risk | High risk hematological diseases (151) | 19.2 | 0.028 |
Standard risk hematological diseases (33) | 3.03 | Â | |
  PH of allo-HSCT | Yes (25) | 32.0 | 0.017 |
No (159) | 13.8 | Â | |
  Donor typre | CBT (135) | 19.3 | 0.076 |
non CBT (49) | 8.16 | Â | |
  Conditioning | RIC(63) | 22.3 | 0.11 |
MAC (121) | 13.2 | Â | |
 Time dependent factors |  |  |  |
  Viridans streptococcal bacteremia | VSB (28) | 10.7 | 0.43 |
non VSB (156) | 17.3 | Â | |
  Engraftment within Day30 | Yes (161) | 9.94 | <0.001 |
No (23) | 60.9 | Â | |
Multivariate analysis | Â | Â | Â |
 Factors | Hazard ratio | 95 % confidence interval | P-value |
  High risk hematological diseases | 5.59 | 0.741–42.18 | 0.095 |
  Prior history of allo-HSCT | 2.09 | 0.919–4.740 | 0.079 |
  CBT | 1.66 | 0.569–4.839 | 0.35 |
  Engraftment within Day30 | 0.22 | 0.087–0.558 | 0.0014 |